P2-Receptor-mediated inhibition of noradrenaline release in the rat pancreas

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 357, Issue 4, 1998, Pages 431-440

  Koch, Helga ^a   Von Kügelgen, Ivar ^a   Starke, Klaus ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

8 Phenyltheophylline; Cibacron blue 3GA; DPCPX; Noradrenaline release; Presynaptic 2 receptor; Presynaptic P2 receptor; Rat pancreas

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 PHENYLTHEOPHYLLINE; ADENOSINE RECEPTOR; CIBACRON BLUE F3GA; PURINE P2 RECEPTOR; SURAMIN;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; NORADRENALIN RELEASE; PANCREAS; PRESYNAPTIC NERVE; SYMPATHETIC NERVE; SYMPATHETIC NERVE CELL;

ANIMALS; MALE; NOREPINEPHRINE; NUCLEOSIDES; NUCLEOTIDES; PANCREAS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2;

EID: 0031956123     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005190     Document Type: Article

References (59)

1. Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64: 445-475
2. 2-purinoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 352: 17-24
3. 2-adrenoceptors. Neuroscience 73: 595-604
4. 2-receptor modulation of noradrenergic neurotransmission in rat kidney. Br J Pharmacol 121: 1255-1262
5. 3H]NECA in rat striutal membranes. Mol Pharmacol 29: 331-346
6. 2y-selective purinoceptor antagonist and an inhibitor of ecto-nucleotidase. Naunyn-Schmiedeberg's Arch Pharmacol 352: 477-482
7. 2-purinoceptor subtypes and ecto-nucleotidases by small aromatic isothiocyanato-sulphon-ates. Naunyn-Schmiedeberg's Arch Pharmacol 354: 481-490
8. 2 adenosine receptors in atria and aorta from the guinea-pig. J Pharm Pharmacol 37: 278-280
9. 2-purinoceptor antagonist in the mouse vas deferens. Br J Pharmacol 93: 243-245
10. 2-adrenoceptor antagonists on norepinephrine release and inhibition of insulin secretion during pancreatic nerve stimulation. Interactions at pre- and postsynaptic sites. In: Langer SZ, Galzin AM, Costentin J (eds) Presynaptic receptors and neuronal transporters. Pergamon Press, Oxford, pp 25-26
11. Forsyth KM, Bjur RA, Westfall DP (1991) Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens. J Pharmacol Exp Ther 256: 821-826
12. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46: 143-156
13. Fuder H, Muscholl E (1995) Heteroreceptor-mediated modulation of noradrenaline and acetylcholine release from peripheral nerves. Rev Physiol Biochem Pharmacol 126: 265-412
14. 2y-like purinoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 348: 352-357
15. 2 values of yohimbine and phentolamine on the perfused rat heart under conditions of negligible autoinhibition. Br J Pharmacol 79: 109-119
16. Fujioka M, Cheung DW (1987) Autoregulation of neuromuscular transmission in the guinea-pig saphenous artery. Eur J Pharmacol 139:147-153
17. Gibbins I (1995) Chemical neuroanatomy of sympathetic ganglia. In: McLachlan EM (ed) Autonomie ganglia. Harwood Academic Publishers, Luxembourg, pp 73-121
18. Göthert M (1980) Somatostatin selectively inhibits noradrenaline release from hypothalamic neurones. Nature 288: 86-88
19. Gonçalves J, Queiroz G (1993) Facilitatory and inhibitory modulation by endogenous adenosine of noradrenaline release in the epididymal portion of rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 348: 367-371
20. 2A-purinoceptors. Br J Pharmacol 117: 156-160
21. Grimm U, Fuder H, Moser U, Bäumert HG, Mutschier E, Lambrecht G (1994) Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 349: 1-10
22. Hansmann G, Bültmann R, Tuluc F. Starke K (1997) Characterization by antagonists of P2-receptors mediating endothelium-depcndent relaxation in the rat aorta. Naunyn-Schmiedeberg's Arch Pharmacol 356:641-652
23. Ishii R, Shinozuka K, Kunitomo M, Hashimoto T, Takeuchi K (1995) Characterization of the facilitatory prejunctional purinoceptor on adrenergic nerves of the rabbit ear artery. J Pharmacol Exp Ther 273: 1390-1395
24. Jänig W, McLachlan EM (1992) Characteristics of function-spezific pathways in the sympathetic nervous system. Trends Neurosci 15: 475-481
25. 2 receptors in rat brain. J Pharmacol Exp Ther 251: 888-893
26. 2A receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release. Naunyn-Schmie-deberg's Arch Pharmacol 355: 48-56
27. Keast JR (1995) Pelvic Ganglia. In: McLachlan EM (ed) Autonomic ganglia. Harwood Academic Publishers, Luxembourg, pp 445-479
28. Koch H, von Kügelgen I. Starke K (1997) P2-Receptor-mediated inhibition of noradrenaline release in the rat hippocampus. Naunyn-Schmiedeberg's Arch Pharmacol 355: 707-715
29. 2-purinoceptors. Br J Pharmacol 110: 1465-1472
30. 2 purinoceptor-mediated responses. Eur J Pharmacol 217: 217-219
31. 2-autoreceptors in rabbit and rat brain cortex in the absence of autoinhibition. Naunyn-Schmiedeberg's Arch Pharmacol 340: 639-647
32. 1 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol 336: 204-210
33. Miyahara H, Suzuki H (1987) Pre- and post-junctional effects of adenosine triphosphate on noradrenergic tansmission in the rabbit ear artery. J Physiol 389: 423-440
34. 2-Adrenergic regulation of galanin and norepinephrine release from canine pancreas. Am J Physiol 262: R819-R825
35. Shimosawa T, Ando K, Ono A, Takahashi K, Isshiki M, Kanda M, Ogata E, Fujita T (1992) Insulin inhibits norepinephrine overflow from peripheral sympathetic nerve ending. Biochem Biophys Res Commun 188: 330-335
36. Shinozuka K, Bjur RA, Westfall DP (1988) Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery. Naunyn-Schmiedeberg's Arch Pharmacol 338: 221-227
37. Shinozuka K, Bjur RA, Westfall DP (1990) Effects of α,β-Methylene ATP on the prejunctional purinoceptors of the sympathetic nerves of the rat caudal artery. J Pharmacol Exp Ther 254: 900-904
38. Singer EA (1988) Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms. Trends Pharmacol Sci 9: 274-276
39. 2 receptor stimulation on transmitter release. J Neurochem 56: 1466-1470
40. Starke K (1987) Presynaptic α-autoreceptors. Rev Physiol Biochem Pharmacol 107: 74-146
41. Starke K, Göthert M, Kilbinger H (1989) Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69: 864-989
42. Story DF, McCulloch MW, Rand MJ, Standford-Starr CA (1981) Conditions required for the inhibitory feedback loop in noradrenergic transmission. Nature 293: 62-65
43. Todorov LD, Bjur RA, Westfall DP (1994) Inhibitory and facilitatory effects of purines on transmitter release from sympathetic nerves. J Pharmacol Exp Ther 268: 985-989
44. 2autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra. Naunyn-Schmiedeberg's Arch Pharmacol 356:721-737
45. 2 purinoceptors. Eur J Pharmacol 268: 1-7
46. von Kügelgen I (1996) Modulation of neural ATP release through presynaptic receptors. Semin Neurosci 8: 247-257
47. 2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 340: 522-532
48. 1-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 346: 187-196
49. 2-pur-inoceptors in feedback control of sympathetic transmitter release. Neuroscience 56: 263-267
50. 2-purinoceptor-mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens. Naunyn-Schmiedeberg's Arch Pharmacol 349: 125-132
51. 2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex. Br J Pharmacol 113: 815-822
52. 2-purinoceptor-mediated inhibition of noradrenaline release in rat atria. Br J Pharmacol 115:247-254
53. 2-purinoceptors at sympathetic axons in mouse atria. Naunyn-Schmie-deberg's Arch Pharmacol 351: R138
54. 2p subtype. Naunyn-Schmiedeberg's Arch Pharmacol 354: 253-261
55. Waud DR (1976) Analysis of dose-response relationships. In: Narahashi T, Bianchi CP (eds) Advances in general and cellular pharmacology, vol 1. Plenum, New York, pp 145-178
56. 2-purinoceptor. Eur J Pharmacol 129: 217-224
57. Williams M, Braunwalder A, Erickson TJ (1986) Evaluation of the binding of the A-1 selective adenosine radioligand, cyclopentyladenosine (CPA), to rat brain tissue. Naunyn-Schmiedeberg's Arch Pharmacol 332: 179-183
58. Woods SC, Porte D (1974) Neural control of the endocrine pancreas. Physiol Rev 54:596-619
59. Zhou QY, Li C, Olah ME, Johnson RA, Stiles GL, Civelli O (1992) Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci USA 89: 7432-7436